atopic dermatitis

Galderma adds new indication for blockbuster hope Nemluvio News
Pharmaphorum
Mon, 12/16/24 - 11:19 am
Galderma
FDA
Nemluvio
atopic dermatitis
AnaptysBio scraps atopic dermatitis asset after antibody fails to meet all endpoints in ph. 2
Fierce Biotech
Wed, 12/11/24 - 11:27 am
AnaptysBio
clinical trials
eczema
atopic dermatitis
ANB032
AbbVie’s RINVOQ shows promise in two Phase III atopic dermatitis trials
Clinical Trials Arena
Thu, 09/26/24 - 11:14 am
AbbVie
Rinvoq
atopic dermatitis
clinical trials
Amgen claims success for two immune drugs, but results underwhelm Wall Street
BioPharma Dive
Wed, 09/25/24 - 11:46 am
Amgen
rocatinlimab
atopic dermatitis
Uplizna
myasthenia gravis
J&J scoops up another atopic dermatitis antibody in $1.25B Numab rights deal
Fierce Biotech
Tue, 05/28/24 - 11:02 am
JNJ
atopic dermatitis
bispecific antibodies
Numab Therapeutics
AbbVie's Rinvoq conquers Regeneron and Sanofi's Dupixent in eczema trial—again
Fierce Pharma
Fri, 04/26/24 - 11:18 am
AbbVie
Rinvoq
Regeneron
Sanofi
Dupixent
atopic dermatitis
Incyte Inks $750M Deal to Buy Escient and Skin Disease Drug Candidates
BioSpace
Tue, 04/23/24 - 09:46 pm
Incyte
M&A
Escient Pharma
atopic dermatitis
FDA updates Sanofi’s Dupixent label for atopic dermatitis
Pharmaceutical Business Review
Wed, 01/17/24 - 09:26 am
Sanofi
Dupixent
FDA
atopic dermatitis
Allakos tumbles after skin disease drug fails mid-stage studies
Reuters
Tue, 01/16/24 - 09:24 am
Allakos
clinical trials
lirentelimab
dermatology
atopic dermatitis
Kymera’s protein degrader starts Phase II trial in atopic dermatitis
Clinical Trials Arena
Fri, 12/8/23 - 11:05 am
Kymera
Sanofi
protein degradation
clinical trials
atopic dermatitis
KT-474
Triveni Bio Launches with $92 Million Series A Financing to Advance Genetics-Informed Precision Medicines for the Treatment of Immunological and Inflammatory (I&I) Disorders
BioSpace
Thu, 10/26/23 - 10:33 am
Triveni Bio
funding
atopic dermatitis
AbbVie’s Rinvoq shows long-term sustained efficacy in atopic dermatitis
Clinical Trials Arena
Thu, 10/12/23 - 10:02 am
AbbVie
clinical trials
Rinvoq
atopic dermatitis
Aclaris finishes enrolment in atopic dermatitis Phase IIb trial of ATI-1777
Clinical Trials Arena
Wed, 10/4/23 - 11:10 am
Aclaris
ATI-1777
atopic dermatitis
JAK inhibitors
FDA Rejects Lilly’s Eczema Treatment Over Third-Party Manufacturing Issues
BioSpace
Mon, 10/2/23 - 10:36 am
Eli Lilly
lebrikizumab
atopic dermatitis
eczema
FDA
drug manufacturing
Nektar Flags Lilly’s Miscalculations in Rezpeg Atopic Dermatitis Trials
BioSpace
Mon, 08/7/23 - 10:51 am
Nektar Therapeutics
Eli Lill
Rezpeg
atopic dermatitis
Incyte’s trial of ruxolitinib cream meets primary endpoint
Clinical Trials Arena
Wed, 07/12/23 - 09:37 am
Incyte
ruxolitinib
clinical trials
pediatric
atopic dermatitis
Apogee Files for IPO with Promising Preclinical Immuno Asset
BioSpace
Sun, 06/25/23 - 09:37 pm
Paragon Therapeutics
IPOs
asthma
atopic dermatitis
Eli Lilly unveils new data from atopic dermatitis therapy trials
Clinical Trials Arena
Tue, 05/2/23 - 10:22 am
Eli Lilly
clinical trial
eczema
atopic dermatitis
lebrikizumab
BenevolentAI lead atopic dermatitis drug misses the mark
Pharmaphorum
Wed, 04/5/23 - 10:04 am
BenevolentAI
clinical trials
BEN-2293
atopic dermatitis
First Protein Degrader Tested Outside Oncology Yields Promising Results
BioSpace
Wed, 12/14/22 - 07:23 pm
Kymera Therapeutics
Sanofi
protein degradation
hidradenitis suppurativa
atopic dermatitis
KT-474

Pages